- Home
- WPP vs TECH Comparison
WPP vs TECH Comparison
Compare WPP & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPP
- TECH
- Stock Information
- Founded
- WPP 1985
- TECH 1976
- Country
- WPP United Kingdom
- TECH United States
- Employees
- WPP N/A
- TECH N/A
- Industry
- WPP Advertising
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WPP Consumer Discretionary
- TECH Health Care
- Exchange
- WPP Nasdaq
- TECH Nasdaq
- Market Cap
- WPP 8.4B
- TECH 7.9B
- IPO Year
- WPP N/A
- TECH 1989
- Fundamental
- Price
- WPP $40.48
- TECH $51.61
- Analyst Decision
- WPP Hold
- TECH Buy
- Analyst Count
- WPP 1
- TECH 10
- Target Price
- WPP N/A
- TECH $73.44
- AVG Volume (30 Days)
- WPP 289.2K
- TECH 2.3M
- Earning Date
- WPP 02-27-2025
- TECH 05-07-2025
- Dividend Yield
- WPP 2.95%
- TECH 0.62%
- EPS Growth
- WPP 389.11
- TECH N/A
- EPS
- WPP 0.62
- TECH 0.83
- Revenue
- WPP $18,454,623,978.00
- TECH $1,208,770,000.00
- Revenue This Year
- WPP N/A
- TECH $8.19
- Revenue Next Year
- WPP $1.46
- TECH $8.61
- P/E Ratio
- WPP $12.65
- TECH $62.17
- Revenue Growth
- WPP N/A
- TECH 4.72
- 52 Week Low
- WPP $31.52
- TECH $46.44
- 52 Week High
- WPP $57.37
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- WPP 64.25
- TECH 49.54
- Support Level
- WPP $38.46
- TECH $46.77
- Resistance Level
- WPP $39.46
- TECH $54.40
- Average True Range (ATR)
- WPP 0.48
- TECH 2.03
- MACD
- WPP 0.42
- TECH 0.70
- Stochastic Oscillator
- WPP 96.29
- TECH 63.43
About WPP WPP plc
Headquartered in the United Kingdom, WPP is one of the world's largest ad holding companies based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.